home / stock / ivevf / ivevf quote
Last: | $3.64 |
---|---|
Change Percent: | 0.0% |
Open: | $3.64 |
Close: | $3.64 |
High: | $3.64 |
Low: | $3.64 |
Volume: | 200 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.64 | $3.64 | $3.64 | $3.64 | $3.64 | 200 | 03-01-2024 |
$3.67 | $3.665 | $3.67 | $3.67 | $3.665 | 3,000 | 11-13-2023 |
$3.73 | $3.73 | $3.73 | $3.73 | $3.73 | 1,000 | 08-22-2023 |
$4.06 | $4.06 | $4.06 | $4.06 | $4.06 | 200 | 08-08-2023 |
$3.95 | $3.95 | $3.95 | $3.95 | $3.95 | 100 | 05-31-2023 |
$5.13 | $0 | $5.13 | $0 | $0 | 170 | 04-17-2023 |
$5.13 | $5.14 | $5.13 | $5.14 | $5.13 | 200 | 02-24-2023 |
$4.95 | $4.95 | $4.95 | $8.4 | $4.95 | 1,500 | 10-07-2022 |
$4.1 | $4.1 | $4.1 | $4.19 | $4.1 | 11,500 | 10-06-2022 |
$13.64 | $13.64 | $13.64 | $13.64 | $13.64 | 100 | 12-03-2021 |
$13.08 | $13.08 | $13.08 | $13.08 | $13.08 | 150 | 11-22-2021 |
$13.18 | $13.18 | $13.18 | $13.18 | $13.18 | 200 | 09-30-2021 |
$11 | $11 | $11 | $11 | $11 | 300 | 09-02-2021 |
$10.84 | $10.84 | $10.84 | $10.84 | $10.84 | 100 | 07-16-2020 |
$12.5905 | $12.5905 | $12.5905 | $12.5905 | $12.5905 | 1,020 | 07-13-2020 |
$14.4 | $15.4 | $14.4 | $15.4 | $14.4 | 1,550 | 07-10-2020 |
$14 | $14 | $14 | $14 | $14 | 100 | 07-06-2020 |
$13.45 | $13.45 | $13.45 | $13.45 | $13.45 | 100 | 07-03-2020 |
$13.45 | $13.45 | $13.45 | $13.45 | $13.45 | 100 | 07-02-2020 |
$ | $N/A | $2.62 | $N/A | $N/A | 0 | 02-12-2020 |
News, Short Squeeze, Breakout and More Instantly...
Inventiva SA Company Name:
IVEVF Stock Symbol:
OTCMKTS Market:
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmaceu...
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic d...
Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmace...